Q Therapeutics

Q Therapeutics is a biotech company in Salt Lake City, United States, founded in 2006. It has raised $15.0M across 1 round, most recently a $15.0M Series B in February 2008.

Advanced cellular therapeutics for incurable CNS diseases

Employees
1–10
Founded
2006
Business Model
B2B
Website
qthera.com
Total Funding
$15.0M
Last Round
$15.0M Series BFeb 2008
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Q Therapeutics has adopted a unique approach to developing human cell-based therapies for debilitating and currently incurable diseases of the brain and spinal cord, focusing on glial cells that support, repair, and maintain normal neuron function. Its lead candidate, Q-Cells, is a human glial progenitor cell therapy with FDA IND allowance to begin a Phase 1/2a clinical trial in transverse myelitis, a spinal cord condition affecting roughly 40,000 people in the US. Q-Cells are an off-the-shelf, allogeneic therapy requiring no genetic manipulation, isolated and purified from brain tissue to perform natural CNS repair functions.

Summary

It lists 1–10 employees. It has raised $15.0M in total across 1 round, most recently a $15.0M Series B round in Feb 2008. Investors include vSpring Capital and EPIC Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BFeb 2008
$15.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Q Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/q-therapeutics"><img src="https://indexed.vc/api/badge/company/q-therapeutics" alt="Q Therapeutics on Indexed.vc" width="260" height="76" /></a>